Howard Allen Ketelson

USPTO Granted Patents = 40 (Patent Applications = 21)

CIPO Patents = 10 (Patent Applications = 1)

EPO Patents = 13 (Patent Applications = 17)

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 82(Granted Patents)

Location History:

Fort Worth, TX (US) (2006 - 2016)
Dallas, TX (US) (2009 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2006-2025

Loading Chart...

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268779 - Ophthalmic emulsion (2025-04-08),

2. 12247028 - Azabicyclo and diazepine derivatives (2025-03-11),

3. 12102559 - Dissolvable polymeric eye inserts and method of using same (2024-10-01),

4. 11884666 - Azabicyclo and diazepine derivatives (2024-01-30),

5. 11779537 - Dissolvable polymeric eye inserts with a biodegradable polymer and method of using the same (2023-10-10),

6. 11730699 - Lipid-based ophthalmic emulsion (2023-08-22),

7. 11690802 - Ophthalmic emulsion (2023-07-04),

8. 11672820 - Ophthalmic compositions with improved dessication protection and retention (2023-06-13),

9. 11395797 - Dissolvable polymeric eye inserts with a biodegradable polymer and method of using same (2022-07-26),

10. 11376275 - Ophthalmic compositions with improved dessication protection and retention (2022-07-05),

11. 11306090 - Azabicyclo and diazepine derivatives (2022-04-19),

12. 11234929 - Ophthalmic emulsion (2022-02-01),

13. 10925892 - Lipid-based ophthalmic emulsion (2021-02-23),

14. 10828320 - Ophthalmic compositions with improved dessication protection and retention (2020-11-10),

15. 10624848 - Ophthalmic emulsion (2020-04-21),

Title: The Innovative Mind of Howard Allen Ketelson

Introduction

Howard Allen Ketelson is a distinguished inventor based in Dallas, TX, known for his significant contributions to the field of eye health through his inventive solutions. With a remarkable portfolio comprising 38 patents, Ketelson has focused his efforts on developing innovative products and methodologies that enhance ocular treatment and patient care.

Latest Patents

Among Ketelson's latest innovations is the development of dissolvable polymeric eye inserts. These inserts are designed to be placed in the cul-de-sac of the eye, where they dissolve to release lubricants, providing prolonged relief and moisture to the ocular surface. This innovation not only enhances the comfort of patients but also aims to reduce the frequency of dosing associated with traditional topical drops. Additionally, Ketelson has worked on azabicyclo and diazepine derivatives, which are valuable as modulators of muscarinic receptors, and have applications in treating various ocular diseases through pharmaceutical compositions.

Career Highlights

Throughout his career, Howard Ketelson has made notable strides in the industry, particularly through his roles at leading companies. He has been associated with Alcon, Inc. and Alcon Research, Ltd., where he has implemented his pioneering ideas and led significant projects directly impacting eye care solutions.

Collaborations

Ketelson's journey in innovation has not only been marked by his individual contributions but also by his collaborations with notable colleagues in the field. He has worked alongside acclaimed professionals such as David L. Meadows and James W. Davis, contributing to a rich exchange of ideas that fuels advancements in ocular health.

Conclusion

In summary, Howard Allen Ketelson exemplifies the spirit of innovation in the realm of eye health. His dedication to developing advanced ocular treatments is reflected in his extensive patent portfolio and collaborations with industry leaders. As he continues to explore new frontiers in eye care, his work is poised to influence both patients and practitioners for years to come.

This text is generated by artificial intelligence and may not be accurate.